These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8998073)
41. The relatively high frequency of p53 gene mutations in multiple and malignant phaeochromocytomas. Yoshimoto T; Naruse M; Zeng Z; Nishikawa T; Kasajima T; Toma H; Yamamori S; Matsumoto H; Tanabe A; Naruse K; Demura H J Endocrinol; 1998 Nov; 159(2):247-55. PubMed ID: 9795365 [TBL] [Abstract][Full Text] [Related]
42. Detection of p53 gene mutations in aspiration biopsy specimens from suspected breast cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Sato T; Okazaki A; Okazaki M; Takahashi S; Hirata K Jpn J Cancer Res; 1995 Feb; 86(2):140-5. PubMed ID: 7730136 [TBL] [Abstract][Full Text] [Related]
43. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Lazarus P; Garewal HS; Sciubba J; Zwiebel N; Calcagnotto A; Fair A; Schaefer S; Richie JP Int J Cancer; 1995 Feb; 60(4):458-63. PubMed ID: 7829258 [TBL] [Abstract][Full Text] [Related]
44. Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma. Iyota K; Takeda K; Matsuzuka F; Okabayashi T; Morita S; Kuma K; Hashimoto K J Endocrinol Invest; 1994 Nov; 17(10):775-82. PubMed ID: 7699210 [TBL] [Abstract][Full Text] [Related]
45. Mutations of p53 tumor-suppressor gene in angiosarcoma. Naka N; Tomita Y; Nakanishi H; Araki N; Hongyo T; Ochi T; Aozasa K Int J Cancer; 1997 Jun; 71(6):952-5. PubMed ID: 9185695 [TBL] [Abstract][Full Text] [Related]
46. Identification of p53 mutations in endometrial adenocarcinoma by polymerase chain reaction-single-strand conformation polymorphism. Wachtel SS; Wachtel G; Shulman LP; Phillips O; Miller B; Photopulos G J Soc Gynecol Investig; 1994; 1(3):234-7. PubMed ID: 9419777 [TBL] [Abstract][Full Text] [Related]
47. Frequent p53 gene mutations in soft tissue sarcomas arising in burn scar. Nakanishi H; Tomita Y; Yoshikawa H; Sato N; Ochi T; Aozasa K Jpn J Cancer Res; 1999 Mar; 90(3):276-9. PubMed ID: 10359041 [TBL] [Abstract][Full Text] [Related]
48. [The methodological specificity of PCR-test of gene p53 in plasma and blood cell DNA of oncological patients]. Bartnovskiĭ AE; Belokhvostov AS; Abramov AA; Likhin FA Klin Lab Diagn; 2003 Nov; (11):19-23. PubMed ID: 14708367 [TBL] [Abstract][Full Text] [Related]
49. Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma. Mayall F; Jacobson G; Wilkins R; Chang B J Clin Pathol; 1998 Aug; 51(8):611-3. PubMed ID: 9828821 [TBL] [Abstract][Full Text] [Related]
50. Fluorescent-based single-strand conformation polymorphism/heteroduplex capillary electrophoretic mutation analysis of the P53 gene. Zhao C; Xu G; Shi X; Ma J; Zhang Y; Lv S; Weng Q; Yang Q Anal Sci; 2004 Jul; 20(7):1001-5. PubMed ID: 15293391 [TBL] [Abstract][Full Text] [Related]
51. A long-term survivor case of malignant mesothelioma treated by recombinant tumor necrosis factor-SAM2 (TNF-alpha mutein) and 5-fluorouracil (5-FU): a new therapeutic approach based on host-tumor relationship. Takagi K; Fukushima Y; Kanou J; Honda T; Tomita K; Takano M; Soma G Anticancer Res; 1998; 18(6B):4591-600. PubMed ID: 9891524 [TBL] [Abstract][Full Text] [Related]
52. Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Welsh JA; Castrén K; Vähäkangas KH Clin Chem; 1997 Dec; 43(12):2251-5. PubMed ID: 9439440 [TBL] [Abstract][Full Text] [Related]
53. Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor. Calvert RJ; Tashiro Y; Buzard GS; Diwan BA; Weghorst CM Cancer Lett; 1995 Aug; 95(1-2):175-80. PubMed ID: 7656227 [TBL] [Abstract][Full Text] [Related]
55. DNA template as a source of artifact in the detection of p53 gene mutations using archived tissue. Shiao YH; Buzard GS; Weghorst CM; Rice JM Biotechniques; 1997 Apr; 22(4):608-10, 612. PubMed ID: 9105605 [No Abstract] [Full Text] [Related]
56. TP53 mutations in human meningiomas. Verheijen FM; Sprong M; Kloosterman JM; Blaauw G; Thijssen JH; Blankenstein MA Int J Biol Markers; 2002; 17(1):42-8. PubMed ID: 11936585 [TBL] [Abstract][Full Text] [Related]
57. Conditions for single strand conformation polymorphism (SSCP)analysis with broad applicability: a study on the effects of acrylamide, buffer and glycerol concentrations in SSCP analysis of exons of the p53 gene). Teschauer W; Mussack T; Braun A; Waldner H; Fink E Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):125-31. PubMed ID: 8833644 [TBL] [Abstract][Full Text] [Related]
58. Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Chu LL; Rutteman GR; Kong JM; Ghahremani M; Schmeing M; Misdorp W; van Garderen E; Pelletier J Breast Cancer Res Treat; 1998 Jul; 50(1):11-25. PubMed ID: 9802616 [TBL] [Abstract][Full Text] [Related]
59. Identification of mutations in 15 Hungarian families with hereditary protein C deficiency. Dávid M; Losonczy H; Sas G; Nagy A; Kutscher G; Meyer M Br J Haematol; 2000 Oct; 111(1):129-35. PubMed ID: 11091192 [TBL] [Abstract][Full Text] [Related]
60. Detection of point mutations by non-isotopic single strand conformation polymorphism. Pinheiro NA; Moura RP; Monteiro E; Villa LL Braz J Med Biol Res; 1999 Jan; 32(1):55-8. PubMed ID: 10347769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]